Grepafloxacin
Grepafloxacin (OPC-17116) is an oral actively fluoroquinolone antibiotic with potent activity against community-acquired respiratory pathogens including Streptococcus pneumonia. Grepafloxacin has high tissue penetration and a promising pharmacodynamic profile[1][2][3].
Product Specifications
CAS Number
119914-60-2
Product Name Alternative
OPC-17116; dl-Grepafloxacin
UNSPSC
12352005
Hazard Statement
H302-H312-H332
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/grepafloxacin.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CN(C2CC2)C3=C(C(C)=C(F)C(N4CC(C)NCC4)=C3)C1=O)O
Molecular Formula
C19H22FN3O3
Molecular Weight
359.39
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P363-P501
References & Citations
[1]Vacher S, et, al. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin. J Antimicrob Chemother. 1999 Nov;44 (5) :647-52.|[2]Owen K. Comparative grepafloxacin phototoxicity in mouse skin. J Antimicrob Chemother. 1998 Aug;42 (2) :261-4.|[3]Cynamon MH, et, al. The activity of grepafloxacin in two murine models of Mycobacterium avium infection. J Infect Chemother. 2004 Jun;10 (3) :185-8.|[4]Miyamoto H, et al. Synthesis and biological properties of substituted 1,4-dihydro-5-methyl-4-oxo-3-quinolinecarboxylic acids. Bioorg Med Chem. 1995;3 (12) :1699-1706.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
Quinolone
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1279353 Inquire
Recombinant Rhizobium leguminosarum bv.viciae DNA-directed RNA polymerase subunit beta (rpoB), partial
Sign In for Pricing
View Details GTR15140363 1 Vial
Lentiviral mouse Padi3 shRNA (UAS) - Lentiviral mouse Padi3 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details 